COVE R S TORY
Sustainability at the forefront for Getinge
Getinge announces its intention to become a CO₂ neutral company by 2025. The target will be reached by a stepwise approach in several areas and supports the company’s objective to contribute to sustainable healthcare environmentally, as well as socially.
The world is facing major challenges, one of which is the ability to provide the increasing world population with safe and effective healthcare. People are living longer and, according to WHO, lifestyle diseases such as cardiovascular diseases are one of the primary causes of death globally. Getinge is committed to working to ensure that all people and societies have access to the best possible health care. The company helps its customers to meet their challenges in health care and life science institutions by providing knowledge, technology and resources to achieve optimal clinical outcomes and, ultimately, to save lives. Acting sustainably means that the company conducts business that is ethically, socially and environmentally sound across the entire value chain. Sustainability is a fundamental part of Getinge’s company strategy to meet customer challenges and healthcare market needs globally. To secure long-term value-creation and competitiveness, sustainability is an integral part of Getinge, as the company actively works to minimise the negative environmental footprint. The organisation is
committed to achieving the Paris agreement goals of limiting global warming to 1.5˚C above pre-industrial levels, and has now made the decision to become CO2
2025.
“In 2012 we started changing the products’ environmental impact over the product life cycle through our EcoDesign principles,” says Mattias Perjos, president and CEO. “This covers all steps from the extraction of raw materials to production, distribution and use, all the way to recycling and disposal. Now we take this a step further, going all CO2
neutral.”
Through the EcoDesign principles, the products’ environmental impact over the product life cycle is taken into account: from the extraction of raw materials to production, distribution and use, all the way to recycling and disposal. This approach is becoming increasingly more important as the market requirements are changing towards product environmental aspects in purchasing by acute care hospitals, laboratories and larger industries. In this regard, EcoDesign offers an opportunity in making a meaningful customer contribution and providing a competitive
Burden of blood
culture contamination Improving safety for neonatal patients Reducing risk of endoscope damage
W W W. C L I N I C A LS E R VI C E S JO U R N A L . C O M VOLUME 19 l ISSUE 10 l NOVEMBER 2020 neutral by THE CLINICAL SERVICES JOURNAL
advantage for Getinge’s sustainable product offerings to the markets globally. Sterile reprocessing continues to be an
important part of Getinge’s portfolio; with a focus on designing, implementing and maintaining world-class sterile workflows for hospitals around the world. In 2019, several innovations were introduced within sterile reprocessing. The GSS610H steam steriliser was launched and an updated version of the 46-series mid-sized washer-disinfector, the S-8668T, was presented to the market. “It is our responsibility to do our utmost to provide our customers with safe and sustainable products,” Mattias Perjos continues. “Within our product offering, we now have a number of products such as the steam steriliser GSS610H, PowerLED II surgical light and the Flow family of anaesthesia products that build on our EcoDesign.”
The GSS610H Steam Steriliser is an excellent example of how Getinge integrates sustainability in the product development.
6 l
WWW.CLINICALSERVICESJOURNAL.COM NOVEMBER 2020
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
